ViroTech LLC  specializes in the development of the new methods for early diagnosis, prognosis, and therapy of various malignancies, with special emphasis on cancers of human reproductive organs.

The proprietary technology of the Company is based on discovery of the new Cancer Virus, deposited in the database of the GenBank under the name of HIV-like Human Cancer Virus (See The Public Release).

Novel diagnostics have been currently developed to determine cancer predisposition and to detect benign,  pre-malignant or malignant   lesions in the breast, ovaries, cervix, uterine, vagina, and vulva in women and prostate or testis in men.

Investors - ViroTech LLC has developed blood tests which allow detecting the virus and starting cancer prevention, even before cancer develops. Don't miss out on this billion dollar market. Imagine Global response when people hear about this breakthrough. Investors click here for Confidentiality Agreement.